Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ACRT about to move to new highs -- Ignore unavailable to you. Want to Upgrade?

To: Andrew Q. Viet who wrote (1267)	1/28/1998 5:49:00 PM
From: Doo	Respond to of 7054

Andrew: Seem like fair comments, to me. Not much for the "criminality" reference in CLST, but we'll see whether Mr. Pink has called that one right. JW

To: Andrew Q. Viet who wrote (1267)	1/28/1998 5:50:00 PM
From: Qualopec	Read Replies (1) \| Respond to of 7054

Another analyst says buy (From Individual Investor's website (iionline.com)) New analyst starts coverage with a buy; we concurÿ(1/28) On January 14, Taglich Brothers analyst Karl Reeves picked up a coverage on ACRT with a buy rating, citing its strong growth prospects. According to Mr. Reeves, the TAD division is growing at 300% annually and returns 35%-45% on the capital it employs. The analyst believes that ACRT will enjoy economies of scale, since there is currently no direct competition in the TAD market. (TAD stands for Trade Acceptance Draft, which are essentially promissory notes that enable buyers to procure goods while providing sellers with immediate cash that can quickly be put to use.) The introduction of the Full Payout TAD and opening of the new credit facility will help ACRT to continue to expand. The company continues to open more offices to meet the increased demand for the TAD program and is on track to obtain its goal of twenty regional offices by the year-end. The potential for the TAD program is huge. Dunn & Bradstreet estimates that the total market potential for TADs is more than $80 billion and ACRT has not even achieved 1% of this market. Mr. Reeves believes that with such strong growth prospects, ACRT's revenues will increase to more than $101 million in 1998 and more than $200 million in 1999, up from $43.4 million in 1997. ACRT will earn between $0.50 and $0.56 per share in 1998 and between $0.82 and $0.90 per share in 1999. His 12 to18 month price target is $40-$50. On this positive note, the shares of ACRT are up more than 2 points today, to $21.82, on volume of more than 350,000 shares. Justin